期刊文献+

血小板参数在强直性脊柱炎治疗效果评价中的作用研究 被引量:4

The efficacy of platelet associated parameters on evaluation of patients with ankylosing spondylitis
下载PDF
导出
摘要 目的研究血小板参数,包括血小板计数(PLT)和平均血小板体积(MPV)与强直性脊柱炎(AS)疾病活动的相关性,探讨其可能的机制。方法测定AS患者治疗前后PLT、MPV,以及急性时相反应物,包括血沉(ESR)、C反应蛋白(CRP)等指标并评估BASDAI和BASFI,比较各指标治疗前后的变化以及各指标之间的相关性,进行统计分析。结果 AS患者治疗后PLT、ESR、CRP测定值及BASDAI和BASFI显著低于治疗前(P<0.05),MPV测定值显著高于治疗前(P<0.05)。治疗前PLT升高组AS患者PLT、ESR、CRP、BASDAI、BASFI等指标均显著高于PLT正常组AS患者(P<0.05),MPV显著低于PLT正常组AS患者(P<0.05)。相关性分析表明PLT和BASDAI、BASFI呈正相关(P<0.05),MPV和BASDAI、BASFI呈负相关(P<0.05)。结论血小板参数PLT、MPV与AS病情活动有关,可作为判断AS疾病活动度的指标。 Objective To investigate the correlation between disease activity of ankylosing spondylitis(AS)and platelet-associated parameters,including platelet count(PLT)and mean platelet volume(MPV).Methods Acute phase reactants(APR),including erythrocyte sedimentation rate(ESR)and C-reactive protein(CRP),along with PLT and MPV were determined and compared before and after AS treatment.Meanwhile,BASDAI and BASFI were evaluated for the correlation analysis to the platelet-associated parameters and APR.Results PLT,ESR,CRP,BASDAI,and BASFI were significantly decreased post-treatment(P〈0.05),MPV was significantly increased post-treatment(P〈0.05).PLT,ESR,CRP,BASDAI,and BASFI were higher,whereas MPV was lower in PLT elevated AS patients prior to treatment.Besides,PLT was positively correlated to BASDAI and BASFI(P〈0.05),MPV was negatively correlated to BASDAI and BASFI(P〈0.05).Conclusion PLT and MPV are correlated to AS disease activity,therefore,PLT and MPV may serve as reference parameters of AS disease activity evaluation.
出处 《中国实用医药》 2011年第6期8-11,共4页 China Practical Medicine
关键词 强直性脊柱炎 血小板计数 平均血小板体积 急性时相反应物 Ankylosing spondylitis Platelet count Mean platelet volume Acute phase reactants
  • 相关文献

参考文献24

  • 1Wang F,Yan CG,Xiang HY,et al.The significance of platelet activation in ankylosing spondylitis.Clin Rheumatol,2008,27(6):767-769.
  • 2Kisacik B,Tufan A,Kalyoncu U,et al.Mean platelet volume(MPV)as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis.Joint Bone Spine,2008,75(3):291-294.
  • 3Weyrich AS,Lindemann S,Zimmerman GA.The evolving role of platelets in inflammation.J Thromb Haemost,2003,1(9):1897-1905.
  • 4Van Der Linden S,Valkenburgh Ha,Cats A.Evaluation of diagnostic criteria for ankylosing spondylitis:a proposal for modification of the New York criteria.Arthritis Rheum,1984,27(4):361-368.
  • 5Garrett S,Jenkinson T,Kennedy LG,et al.A new approach to defining disease status in ankylosing spondylitis:the bath ankylosing spondylitis disease activity index.J Rheumatol,1994,21(12):2286-2291.
  • 6Calin A,Garrett S,Whitelock H,et al.A new approach to defining functional ability in ankylosing spondylitis:the development of the Bath Ankylosing Spondylitis Functional Index.J Rheumatol,1994,21(12):2281-2285.
  • 7苏金梅,张文,唐福林.强直性脊柱炎研究进展——2008年欧洲风湿病联盟年会纪要[J].中华临床免疫和变态反应杂志,2009,3(1):78-79. 被引量:12
  • 8Shmerling RH.Diagnostic tests for rheumatic disease:clinical utility revisited.South Med J,2005,98(7):704-711.
  • 9Yildirim K,Karatay S,Melikoglu MA,et al.Associations between acute phase reactant levels and disease activity score(DAS28)in patients with rheumatoid arthritis.Ann Clin Lab Sci,2004,34(4):423-426.
  • 10Pincus T,Sokka T.Laboratory tests to assess patients with rheumatoid arthritis:advantages and limitations.Rheum Dis Clin North Am,2009,35(4):731-734.

二级参考文献4

  • 1王利军,杨林花,李小峰.细胞因子在类风湿关节炎血小板升高机制中的作用及研究进展[J].中华风湿病学杂志,2005,9(1):53-55. 被引量:12
  • 2Kiraz S,Ertenli I,Ozturk MA.Bloodstream thrombopoietin in rheumatoid arthritis with thrombocytosis.Clin Rheumatol,2002,21:453-456.
  • 3Kaser A,Brandacher G,Steurer W.Interleukin-6 stimulates thrombopoiesis through thrombopoietin:role in inflammatory thrombocytosis.Blood,2001,98:2720-2725.
  • 4Cerutti A,Custodi P,Mduranti.Circulating thrombopoietin in reactive conditions behaves like an acute phase reactant.Clin Lab Haematol,1999,21:271-275.

共引文献16

同被引文献53

引证文献4

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部